Druckansicht
 
 

Triple-Negative Breast Cancer: Exploiting Tumor Biology to Improve Patient Outcomes

Physicians Education Resource
Archiv
-
04.06.2010  Chicago
This presentation was selected by the American Society of Clinical Oncology® as an independent educational activity held adjunct to the ASCO Annual Meeting. This presentation is not sponsored or endorsed by ASCO.
 
Kursinhalte
Satellite symposium will review the latest advances in the biology and treatment of triple-negative breast cancer. Lectures will highlight the rationale for targeted therapy in triple-negative disease and will include cutting-edge information on cytotoxic and targeted agents currently under investigation for this patient population. Investigational strategies and high-priority clinical trials will also be discussed. The symposium will emphasize placing key data into a clinical context...
Lernziele, Trainingsziele
Please see our website for all the details www.cancerlearning.com
Zielpublikum
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healt
Anmerkungen
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/542
 

Anfragen und Anmeldung:

Herr Duane Fowler
001 888 949 0045
 
Kategorien
Onkologie
Sprache
Englisch
Kosten
complimentary
Veranstalter Kontakt
3500 Maple Ave. Ste. 700
75219 Dallas
USA
Tel: 001 888 949 0045
Fax: 001 314 367 3305
info@cancerlearning.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

AGEM - Arbeitsgemeinschaft Ethnomedizin e. V.newTreeEuropean Public Health Association (EUPHA)Center of ExcellenceHelix - Forschung & Beratung WienCharité International AcademyÖsterreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.

Facebook

Sagen Sie uns Ihre professionelle Meinung

Zur Umfrage

Zur Umfrage